About Fibroblast
Fibroblast is a company based in Chicago (United States) founded in 2011 was acquired by Cerner in October 2020. Fibroblast has raised $3.23 million across 4 funding rounds from investors including Cerner and Excelerator Titan. Fibroblast operates in a competitive market with competitors including eHealth Technologies, RubiconMD, Refer Well, Clarity Health and par8o, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fibroblast, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fibroblast
Fibroblast has successfully raised a total of $3.23M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fibroblast
Fibroblast has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Cerner and Excelerator Titan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated through a 13-week program in Chicago.
|
Locked | Locked | Locked | |
|
Online platform for employee health benefits
|
Locked | Locked | Locked |
Investor details for Fibroblast
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fibroblast
Investment portfolio details for Fibroblast
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fibroblast
Detailed financials for Fibroblast
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fibroblast Comparisons
Peer comparison for Fibroblast
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fibroblast
Fibroblast operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eHealth Technologies, RubiconMD, Refer Well, Clarity Health and par8o, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Referral solutions for healthcare providers
|
|
| Locked | Locked | Locked |
Remote consults are enabled between primary care physicians and specialists.
|
|
| Locked | Locked | Locked |
Cloud-based platform for healthcare referral management is provided.
|
|
| Locked | Locked | Locked |
Care coordination solutions are delivered to healthcare organizations.
|
|
| Locked | Locked | Locked |
Patient referrals are managed via cloud-based analytics and mobile alerts.
|
|
| Locked | Locked | Locked |
Cloud-based care coordination software is provided for healthcare professionals.
|
Detailed competitors of Fibroblast
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fibroblast
Complete news archive for Fibroblast
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fibroblast
Fibroblast was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Fibroblast is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Fibroblast is a funded company, having raised a total of $3.23M across 4 funding rounds to date.
Fibroblast was founded in 2011 in Chicago, United States, and operates as a SaaS platform in the healthcare sector. Patient referrals are automated through the system, with tools provided for providers to manage referrals actively. Operations focus on reducing patient leakage, supporting revenue growth for fee-for-service entities, and mitigating risks for accountable care organizations across the United States.
Fibroblast's top competitors include eHealth Technologies, RubiconMD and Refer Well.
Fibroblast has 2 investors. Key investors include Cerner, and Excelerator Titan.